Lantheus Holdings, Inc.
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound en…
Drug Manufacturers - Specialty & Generic
US, North Billerica [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Lantheus Holdings, Inc. (LNTH) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drug Manufacturers—Specialty & Generic Average | - - | - - | - - | 237,667.87 | 40,607.86 | 1,655.30 | 60,837.70 | -447.91 | 0.01 | 43.9153 | 84.73 | 0.4318 | -0.3778 | 0.00 | 0.01 | 2.3862 | - - | ||
| Maximum | - - | - - | - - | 8,626,028.00 | 528,312.00 | 32,061.00 | 1,988,352.00 | 16,134.00 | 0.08 | 2,279.6263 | 3,215.80 | 1.0000 | 1.6542 | 0.13 | 1.46 | 35.1990 | - - | ||
| Minimum | - - | - - | - - | 0.00 | 0.00 | -15,489.00 | -277,041.00 | -30,106.00 | 0.00 | -1,306.5021 | -853.08 | -3.9254 | -42.3731 | -0.31 | -0.90 | 0.0000 | - - | ||
| Alkermes plc ALKS | 28.78 | 1.08 3.90% | 2,060 vs. 1,707 | 4,656.00 | 350.00 | 36.00 | 12.00 | -1,306.00 | 0.2200 | 31.0625 | 0.0000 | 0.8256 | 0.1051 | 0.0294 | 0.0173 | 2.3141 | 161.00 | ||
| Neurocrine Biosciences, Inc. NBIX | 125.65 | 0.65 0.52% | 1,181 vs. 1,016 | 12,721.00 | 515.00 | 43.00 | 119.00 | -113.00 | 0.4300 | 81.2772 | 0.0000 | 0.9752 | 0.0842 | 0.0182 | 0.0125 | 2.3303 | 101.00 | ||
| Catalent, Inc. CTLT | 60.98 | 1.32 2.21% | 4,869 vs. 1,690 | 11,068.00 | 1,074.00 | -101.00 | -62.00 | -804.00 | -0.5500 | -25.4034 | 0.0000 | 0.2132 | -0.0940 | -0.0280 | -0.0102 | 1.5571 | 181.00 | ||
| Lantheus Holdings, Inc. LNTH | 90.52 | 3.20 3.66% | 2,009 vs. 909 | 6,293.00 | 369.00 | 131.00 | 118.00 | 264.00 | 1.9100 | 7.8834 | 0.0000 | 0.6805 | 0.3543 | 0.1386 | 0.0716 | 4.4506 | 69.00 | ||
| Amphastar Pharmaceuticals, Inc. AMPH | 45.46 | 0.91 2.04% | 394 vs. 349 | 2,185.00 | 171.00 | 43.00 | 46.00 | 452.00 | 0.9000 | 12.1264 | 0.0000 | 0.5080 | 0.2513 | 0.0642 | 0.0274 | 1.6856 | 48.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.